Complementarity-Determining Region 3 (CDR3) of the Heavy Chain Only Antibodies: Therapeutic Perspectives
Authors
Lea Talpašová
Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, Košice
Katarína Bhide
Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, Košice
Tomáš Maľarik
Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, Košice
Mangesh Bhide
Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, Košice
Institute of Neuroimmunology, Slovak Academy of Sciences v. v. i., Bratislava, Slovakia
Language: English
Page range: 64 - 71
Submitted on: Apr 4, 2024
Accepted on: May 21, 2024
Published on: Jun 27, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2024 Lea Talpašová, Katarína Bhide, Tomáš Maľarik, Mangesh Bhide, published by The University of Veterinary Medicine and Pharmacy in Košice
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
